|
OriGene Technologies was founded as a research tool company focused on the creation of the large commercial collection of full-length human cDNAs in a standard expression vector. OriGene´s vision is to prepare comprehensive, genome wide research tools and technology platforms to enable scientists to study complete biological pathways, thus enabling a better understanding of disease mechanisms including cancer and stem cell research.
OriGene Technologies uses high-throughput, genome wide approach to develop products for pharmaceutical, biotechnology, and academic research. Our flagship product is the cDNA clone collection, a searchable gene bank of over 40,000 human full-length TrueClone cDNA collection and over 35,000 human TrueORF cDNA clones. From our TrueORF cDNA clones, we have developed the broad offering of full length human proteins, such as “MVPro” proteins, expressed in mammalian cells, ideal for functional studies.
In 2010, OriGene initiated the TrueMAB™ project to develop mouse monoclonal antibodies against protein antigens with the goal to develop protein assays for every human protein. OriGene also began the TrueRAB™ project to develop single B cell cloning technology for the generation of recombinant rabbit monoclonal antibodies with high affinity and against targets with low immunogenicity in mouse system.
In addition, OriGene offers different gene expression products such as TissueScan cancer tissue qPCR arrays and tissue biorepository for biomarker discovery and validation
|
